Catalyst Event
3SBio Inc (1530) · Other
From Akros SCHK HK-U.S. Biotech Index (ASHUBIO)
7/21/2026, 12:00:00 AM
The ex-dividend date for the final cash dividend of HKD 0.25 per share for the fiscal year 2025 is July 21, 2026, scheduled.
Korean Translation
2025년 회계연도 기말 현금 배당(주당 0.25 홍콩달러)에 대한 2026년 7월 21일 배당락일 예정됨.
Related Recent Events
3SBio Inc (1530) · Earnings Release
First half 2026 earnings results are expected to be released around August 26, 2026, expected. High importance is estimated due to the significant impact of previous earnings growth on stock volatility.
8/26/2026, 12:00:00 AM
Sino Biopharmaceutical Ltd (1177) · Other
The ex-dividend date for the proposed final dividend of HKD 0.05 per share is 2026-06-24, which is estimated to have a price impact of ≥1% scheduled.
6/24/2026, 12:00:00 AM
Innovent Biologics Inc (1801) · Other
Innovent will present obesity pipeline data at the ADA Scientific Sessions on June 5-8, 2026; this low-impact event is scheduled
6/5/2026, 12:00:00 AM
Giant Biogene Holding Co Ltd (2367) · Other
Ex-dividend date of 2026-06-01 for final and special dividends, scheduled. (Estimated Low impact as dividend is standard).
6/1/2026, 12:00:00 AM
CSPC Pharmaceutical Group Ltd (1093) · Earnings Release
Q1 2026 earnings release scheduled. Analysts forecast revenue of 7.52B HKD. Estimated Medium importance as earnings results typically drive significant price movement scheduled.
5/27/2026, 12:00:00 AM
Amgen Inc (AMGN) · Other
The ex-dividend date for Amgen's Q2 2026 dividend of $2.52 per share is scheduled for May 15, 2026. The dividend is payable on June 5, 2026, to shareholders of record on the ex-date scheduled.
5/15/2026, 12:00:00 AM